Dutasteride and PP405 Interaction
Dutasteride and PP405 have a compatible interaction with 90% confidence. Different mechanisms of action. Dutasteride inhibits both Type I and Type II 5-alpha reductase to block DHT, while PP405 acts on mitochondrial pyruvate carriers in hair follicle stem cells. No overlapping pathways suggest safe co-administration. Both compounds affect the skin, so monitoring these systems is recommended.
Compound Profiles
Dutasteride
Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH
Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.
View full profilePP405
MPC Inhibitor | Hair Follicle Stem Cell Activation
PP405 is a dual inhibitor of the mitochondrial pyruvate carrier complex, targeting both the MPC1 and MPC2 subunits. Under normal conditions, the MPC transports pyruvate from the cytoplasm into the mitochondrial matrix, where it enters the tricarboxylic acid (TCA) cycle for oxidative metabolism.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take Dutasteride with PP405?
Yes, Dutasteride and PP405 can generally be taken together. Different mechanisms of action. Dutasteride inhibits both Type I and Type II 5-alpha reductase to block DHT, while PP405 acts on mitochondrial pyruvate carriers in hair follicle stem cells. No overlapping pathways suggest safe co-administration.
Is Dutasteride and PP405 safe together?
Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.
What are the interactions between Dutasteride and PP405?
Different mechanisms of action. Dutasteride inhibits both Type I and Type II 5-alpha reductase to block DHT, while PP405 acts on mitochondrial pyruvate carriers in hair follicle stem cells. No overlapping pathways suggest safe co-administration. This assessment has 90% confidence and is based on documented research data.
How should I time Dutasteride and PP405?
Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months) and PP405 has a half-life of Topical application; exact pharmacokinetics not published. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.